Specific Activation of the Alternative Cardiac Promoter of Cacna1c by the Mineralocorticoid Receptor

Circulation Research
Thassio R MesquitaJean-Pierre Benitah

Abstract

The MR (mineralocorticoid receptor) antagonists belong to the current therapeutic armamentarium for the management of cardiovascular diseases, but the mechanisms conferring their beneficial effects are poorly understood. Part of the cardiovascular effects of MR is because of the regulation of L-type Cav1.2 Ca2+ channel expression, which is generated by tissue-specific alternative promoters as a long cardiac or short vascular N-terminal transcripts. To analyze the molecular mechanisms by which aldosterone, through MR, modulates Cav1.2 expression and function in a tissue-specific manner. In primary cultures of neonatal rat ventricular myocytes, aldosterone exposure for 24 hours increased in a concentration-dependent manner long cardiac Cav1.2 N-terminal transcripts expression at both mRNA and protein levels, correlating with enhanced concentration-, time-, and MR-dependent P1-promoter activity. In silico analysis and mutagenesis identified MR interaction with both specific activating and repressing DNA-binding elements on the P1-promoter. The relevance of this regulation is confirmed both ex and in vivo in transgenic mice harboring the luciferase reporter gene under the control of the cardiac P1-promoter. Moreover, we show that t...Continue Reading

References

Dec 3, 1999·Biochemical and Biophysical Research Communications·V KollaG Litwack
Apr 6, 2000·American Journal of Physiology. Heart and Circulatory Physiology·L LiuJ D Marsh
Oct 3, 2000·Journal of Molecular and Cellular Cardiology·I Q FanJ D Marsh
Jan 5, 2002·The New England Journal of Medicine·K T Weber
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alan M Michelson
Mar 26, 2003·Annual Review of Biochemistry·Stephen T Smale, James T Kadonaga
Mar 25, 2004·Expert Review of Cardiovascular Therapy·Adelle DawsonAllan D Struthers
Apr 2, 2005·Molecular Endocrinology·Laurent Pascual-Le Tallec, Marc Lombès
May 3, 2005·Steroids·Anastasia S Mihailidou, John W Funder
May 7, 2005·Molecular and Cellular Endocrinology·Christoph GeserickBernard Haendler
Sep 17, 2005·The Journal of Physiology·Romain PerrierJean-Pierre Bénitah
Apr 13, 2007·Physiological Reviews·Henk E D J Ter Keurs, Penelope A Boyden
Jan 5, 2008·Nuclear Receptor Signaling·Say ViengchareunMarc Lombès
Mar 11, 2008·Trends in Genetics : TIG·Ramana V DavuluriTim H-M Huang
Apr 18, 2009·Science·Sebastiaan H MeijsingKeith R Yamamoto
Aug 8, 2009·Journal of Molecular and Cellular Cardiology·Jean-Pierre BenitahAna María Gómez
Apr 29, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Kimberly C Gilbert, Nancy J Brown
Nov 6, 2012·International Journal of Cardiology·Robert J MentzBertram Pitt
Feb 5, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Biny K JosephSung W Rhee
May 8, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Robert E Hill, Laura A Lettice
Jan 3, 2014·Physiological Reviews·Franz HofmannJörg W Wegener
Dec 3, 2014·JACC. Heart Failure·Laurent CalvierNatalia López-Andrés
Dec 4, 2014·International Journal of Cardiology·Francesco PellicciaCarlo Gaudio
Feb 5, 2015·Trends in Genetics : TIG·Eleonora de Klerk, Peter A C 't Hoen
May 15, 2015·Current Molecular Pharmacology·Sharon Weiss, Nathan Dascal
Dec 31, 2015·Proceedings of the National Academy of Sciences of the United States of America·William H HudsonEric A Ortlund
Mar 13, 2016·Journal of Neuroendocrinology·E R de KloetM Joëls
Jan 6, 2017·Nature Reviews. Molecular Cell Biology·Emily R WeikumKeith R Yamamoto

❮ Previous
Next ❯

Citations

Sep 8, 2018·American Journal of Hypertension·Mathieu BuonafineFrédéric Jaisser
Sep 16, 2019·Experimental Eye Research·Jonatan Barrera-Chimal, Frederic Jaisser
Feb 19, 2020·Pharmacology & Therapeutics·Boris ManouryRodolphe Fischmeister

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

© 2022 Meta ULC. All rights reserved